Tokyo, Feb. 18 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060690) titled 'Drug Use-Results Survey of ELEVIDYS for Injection (All-Patient Surveillance)' on Feb. 17.
Study Type:
Observational
Primary Sponsor:
Institute - Chugai Pharmaceutical Co. Ltd.
Condition:
Condition - Duchenne Muscular Dystrophy
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The primary objective is to understand the long-term safety profile (incidence rate, time of onset, outcome, etc.) of this product under real-world usage conditions. Secondarily, long-term efficacy parameters will also be assessed.
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower lim...